Geneseeq
PrivateLast Round
Growth Equity
Oct 19, 2020
Est. Valuation
$902.2M
Total Funding Raised
$531.71M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Geneseeq is a precision oncology company that provides genomic profiling technology to accelerate precision cancer care.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Medical Devices, Healthcare Analytics
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Geneseeq Comparables
Compare Geneseeq with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HaploX | 87% | |
| Beijing Geneplus Technology | 87% | |
| 求臻医学 | 87% |
Geneseeq Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Oct 19, 2020 | ||||
| Growth Equity | Jan 5, 2020 | ||||
| Series D | Dec 26, 2019 | ||||
| Series C | Nov 23, 2017 | ||||
| Series C | Jul 20, 2017 | ||||
Series B Extension | Feb 1, 2017 |
Geneseeq Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| China Resources Pharmaceutical Industry Investment Fund | Growth Equity |
| Xingzheng Innovation Capital | Series C |
| E Fund Management | Series D |
| Lilly Asia Ventures | Series D |
| China Reform Holdings Corporation | Series D |
| Lilly Asia Ventures | Series D |
| 朗玛峰创投 | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 25, 2026
Grew 17% QoQ from 35 to 41 employees.
- Aug 10, 2026
Open roles increased to 127, 363% of headcount.
Recent news
Latest coverage and updates
- partners_withAug 11, 2026
Geneseeq Technology Inc. partnered with Roche on Aug 11th '26.
- partners_withJul 14, 2026
Geneseeq Technology Inc. partnered with University Health Network on Jul 14th '26.
Geneseeq Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Geneseeq's valuation, stock price, and market status.
Is Geneseeq a public or private company?
Geneseeq is a private company.
What is the current stock price of Geneseeq?
Geneseeq is a private company with no public stock price. No recent secondary market data is available.
How much is Geneseeq worth (valuation)?
Geneseeq's valuation is estimated at $45.6M based on funding round data.
Can I buy Geneseeq stock?
Geneseeq shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Geneseeq's last funding round?
Geneseeq's most recent funding round was Growth Equity on June 1, 2016.
Who are the main investors in Geneseeq?
Key investors in Geneseeq include China Resources Pharmaceutical Industry Investment Fund.
Will Geneseeq IPO soon?
No public IPO plans have been announced for Geneseeq.
How can I track Geneseeq secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Geneseeq's secondary market activity and sign up for updates.